細胞凍結保存の世界市場：製品・用途・エンドユーザー・地域別の機会および予測 (2018-2032年)

世界の細胞凍結保存の市場規模は、予測期間中にCAGR 21.0％で推移し、2024年の111億9,000万米ドルから、2032年には508億8,000万米ドルに成長すると予測されています。

同市場は、さまざまな疾患に対する細胞治療の利用拡大、バイオバンクへの需要増加、体外受精（IVF）クリニックからの要求の高まり、生物試料の長期保存に向けた取り組み、市場の主要企業による技術的に進化した装置の導入努力によって支えられ、着実に成長を遂げています。

さらに、幹細胞、臓器、血液の提供を多様な民族間で促進するための各国政府の取り組みも、市場成長を後押ししています。たとえば、2023年にはイングランドおよびウェールズ全域で50の団体・地域グループが、アジア系および黒人コミュニティの健康格差解消に向けた英国政府の取り組みの一環として、約89万米ドル（68万5,000ポンド）の助成金を受け取りました。これは、以前はCommunity Investment Schemeとして知られていたCommunity Grants Programで、NHSBT (National Health Service Blood and Transplant) が管理し、アジア系および黒人の人々がドナーとなることを促進するプロジェクトに資金を提供するものです。

また、主要企業による先進的な製品・技術の開発と提供体制の強化も、市場の拡大に積極的に寄与しています。2024年9月には、Dover Corporation傘下のColder Products Company（CPC）が、遺伝子・細胞治療プロセスで使用される凍結カセットに直接接続可能な新型無菌マイクロコネクターを発表しました。

市場のリーディング企業であるMerck KGaA、Thermo Fisher Scientific Inc.、Lonza Ltd.などは、凍結保存技術と革新的な製品群で確固たる地位を築いています。これらの企業は、バイオ保存に関する研究に積極的に投資しており、凍結保存培地、冷凍技術、自動化の分野で継続的なイノベーションを推進しています。また、バイオテック企業、研究機関、バイオバンクとの戦略的パートナーシップや協業にも注力しており、業界が直面する課題に対応するための新たな技術やプロトコルの開発にも取り組んでいます。

当レポートでは、世界の細胞凍結保存の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分別の詳細分析、産業構造、市場成長への影響因子の分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の細胞凍結保存市場の展望

• 市場規模の分析・予測
• 市場シェアの分析・予測
  • 製品別
    • 消耗品
    • 細胞凍結培地
    • 装置
  • 用途別
    • 幹細胞
    • 卵母細胞・胚細胞
    • 精子細胞
    • 肝細胞
    • その他
  • エンドユーザー別
    • バイオ医薬品・製薬会社
    • 研究機関
    • バイオバンク
    • 体外受精クリニック
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 南米
    • 中東・アフリカ
  • 企業シェア分析 (上位5社およびその他)
• 市場マップ分析

第5章 北米の細胞凍結保存市場の展望

• 市場規模の分析・予測
• 市場シェアの分析・予測
• 国別市場評価
  • カナダ
  • メキシコ

第6章 欧州の細胞凍結保存市場の展望

• ドイツ
• スペイン
• フランス
• 英国
• イタリア
• トルコ
• ロシア
• オランダ
• ポーランド

第7章 アジア太平洋の細胞凍結保存市場の展望

• 中国
• 日本
• インド
• 韓国
• オーストラリア
• ベトナム
• インドネシア
• フィリピン

第8章 中東・アフリカの細胞凍結保存市場の展望

• サウジアラビア
• UAE
• 南アフリカ

第9章 南米の細胞凍結保存市場の展望

• ブラジル
• アルゼンチン

第10章 市場マップ分析

• 製品別
• 用途別
• エンドユーザー別
• 地域別

第11章 需給分析

第12章 輸出入分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 PESTLE分析

第16章 価格分析

第17章 市場力学

• 市場促進要因
• 市場の課題

第18章 市場動向・展開

第19章 臨床試験とイノベーション

• 臨床試験
• イノベーション

第20章 特許の情勢

第21章 ケーススタディ

第22章 競合情勢

• 上位5社の競合マトリックス
• 上位5社のSWOT分析
• 上位10社の情勢
  • Merck & Co., Inc.
  • Thermo Fisher Scientific Inc.
  • Lonza Group Ltd.
  • GE HealthCare Technologies Inc.
  • BioLife Solutions Inc.
  • Sartorius AG
  • STEMCELL Technologies Canada Inc.
  • Artivion, Inc
  • Takara Bio Inc.
  • Corning Incorporated

第23章 戦略的提言

第24章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1: Global Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 2: Global Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 3: Global Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 4: Global Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 5: Global Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 6: Global Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 7: Global Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 8: Global Cell Cryopreservation Market Share, By Region, By Value, 2018-2032F
• Figure 9: Market Share of Top Five Companies, 2024
• Figure 10: North America Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 11: North America Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 12: North America Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 13: North America Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 14: North America Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 15: North America Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 16: North America Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 17: North America Cell Cryopreservation Market Share, By Country, By Value, 2018-2032F
• Figure 18: United States Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 19: United States Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 20: United States Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 21: United States Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 22: United States Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 23: United States Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 24: United States Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 25: Canada Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 26: Canada Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 27: Canada Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 28: Canada Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 29: Canada Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 30: Canada Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 31: Canada Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 32: Mexico Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 33: Mexico Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 34: Mexico Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 35: Mexico Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 36: Mexico Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 37: Mexico Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 38: Mexico Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 39: Europe Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 40: Europe Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 41: Europe Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 42: Europe Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 43: Europe Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 44: Europe Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 45: Europe Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 46: Europe Cell Cryopreservation Market Share, By Country, By Value, 2018-2032F
• Figure 47: Germany Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 48: Germany Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 49: Germany Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 50: Germany Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 51: Germany Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 52: Germany Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 53: Germany Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 54: France Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 55: France Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 56: France Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 57: France Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 58: France Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 59: France Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 60: France Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 61: Spain Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 62: Spain Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 63: Spain Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 64: Spain Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 65: Spain Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 66: Spain Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 67: Spain Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 68: Italy Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 69: Italy Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 70: Italy Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 71: Italy Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 72: Italy Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 73: Italy Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 74: Italy Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 75: United Kingdom Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 76: United Kingdom Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 77: United Kingdom Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 78: United Kingdom Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 79: United Kingdom Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 80: United Kingdom Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 81: United Kingdom Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 82: Russia Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 83: Russia Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 84: Russia Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 85: Russia Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 86: Russia Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 87: Russia Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 88: Russia Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 89: Turkey Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 90: Turkey Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 91: Turkey Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 92: Turkey Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 93: Turkey Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 94: Turkey Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 95: Turkey Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 96: Netherlands Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 97: Netherlands Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 98: Netherlands Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 99: Netherlands Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 100: Netherlands Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 101: Netherlands Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 102: Netherlands Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 103: Poland Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 104: Poland Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 105: Poland Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 106: Poland Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 107: Poland Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 108: Poland Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 109: Poland Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 110: Asia-Pacific Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 111: Asia-Pacific Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 112: Asia-Pacific Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 113: Asia-Pacific Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 114: Asia-Pacific Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 115: Asia-Pacific Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 116: Asia-Pacific Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 117: Asia-Pacific Cell Cryopreservation Market Share, By Country, By Value, 2018-2032F
• Figure 118: China Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 119: China Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 120: China Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 121: China Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 122: China Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 123: China Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 124: China Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 125: Japan Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 126: Japan Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 127: Japan Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 128: Japan Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 129: Japan Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 130: Japan Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 131: Japan Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 132: India Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 133: India Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 134: India Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 135: India Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 136: India Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 137: India Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 138: India Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 139: South Korea Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 140: South Korea Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 141: South Korea Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 142: South Korea Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 143: South Korea Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 144: South Korea Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 145: South Korea Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 146: Australia Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 147: Australia Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 148: Australia Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 149: Australia Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 150: Australia Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 151: Australia Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 152: Australia Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 153: Vietnam Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 154: Vietnam Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 155: Vietnam Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 156: Vietnam Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 157: Vietnam Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 158: Vietnam Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 159: Vietnam Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 160: Indonesia Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 161: Indonesia Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 162: Indonesia Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 163: Indonesia Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 164: Indonesia Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 165: Indonesia Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 166: Indonesia Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 167: Philippines Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 168: Philippines Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 169: Philippines Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 170: Philippines Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 171: Philippines Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 172: Philippines Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 173: Philippines Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 174: Middle East and Africa Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 175: Middle East and Africa Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 176: Middle East and Africa Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 177: Middle East and Africa Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 178: Middle East and Africa Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 179: Middle East and Africa Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 180: Middle East and Africa Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 181: Middle East and Africa Cell Cryopreservation Market Share, By Country, By Value, 2018-2032F
• Figure 182: Saudi Arabia Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 183: Saudi Arabia Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 184: Saudi Arabia Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 185: Saudi Arabia Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 186: Saudi Arabia Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 187: Saudi Arabia Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 188: Saudi Arabia Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 189: UAE Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 190: UAE Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 191: UAE Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 192: UAE Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 193: UAE Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 194: UAE Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 195: UAE Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 196: South Africa Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 197: South Africa Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 198: South Africa Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 199: South Africa Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 200: South Africa Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 201: South Africa Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 202: South Africa Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 203: South America Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 204: South America Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 205: South America Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 206: South America Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 207: South America Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 208: South America Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 209: South America Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 210: South America Cell Cryopreservation Market Share, By Country, By Value, 2018-2032F
• Figure 211: Brazil Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 212: Brazil Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 213: Brazil Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 214: Brazil Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 215: Brazil Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 216: Brazil Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 217: Brazil Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 218: Argentina Cell Cryopreservation Market Size, By Value (USD Billion), 2018-2032F
• Figure 219: Argentina Cell Cryopreservation Market Share, By Product, By Value, 2018-2032F
• Figure 220: Argentina Cell Cryopreservation Market Share, By Product, By Consumables, By Value, 2018-2032F
• Figure 221: Argentina Cell Cryopreservation Market Share, By Product, By Cell Freezing Media, By Value, 2018-2032F
• Figure 222: Argentina Cell Cryopreservation Market Share, By Product, By Equipment, By Value, 2018-2032F
• Figure 223: Argentina Cell Cryopreservation Market Share, By Application, By Value, 2018-2032F
• Figure 224: Argentina Cell Cryopreservation Market Share, By End-user, By Value, 2018-2032F
• Figure 225: Global Cell Cryopreservation Market Map, By Product, By Value, 2024
• Figure 226: Global Cell Cryopreservation Market Map, By Application, By Value, 2024
• Figure 227: Global Cell Cryopreservation Market Map, By End-user, By Value, 2024
• Figure 228: Global Cell Cryopreservation Market Ma

Global cell cryopreservation market is projected to witness a CAGR of 21.0% during the forecast period 2025-2032, growing from USD 11.19 billion in 2024 to USD 50.88 billion in 2032. The market's growth is supported by the increasing utilization of cell therapies in various diseases, rising requirements for biobanks, increasing requirements from IVF clinics, growing efforts to preserve biological specimens for longer periods, and rising efforts of the key players of the market to introduce technologically advanced equipment.

Additionally, the rising efforts of different governments to promote stem cells, organs, and blood donations among different ethnicities are also boosting the growth of the cell cryopreservation market. In 2023, fifty organizations and community groups across Wales and England received a share from funding of approximately USD 890,000 (£685,000) as part of the government's efforts to tackle health inequalities among Asian and Black communities. Previously known as the Community Investment Scheme, the Community Grants Program is managed by the National Health Service Blood and Transplant (NHSBT) and aids in funding community organizations to deliver projects that encourage more Asian and Black individuals to become donors.

Furthermore, the rising efforts of leading companies to augment the availability of novel and advanced products and technologies are also positively influencing the expansion of the global cell cryopreservation market. In September 2024, Colder Products Company (CPC), a part of the Dover Corporation, announced the launch of a novel aseptic micro-connector that has the ability to fit directly into the freeze cassettes used in gene and cell therapy processing. Cryopreservation aids in minimizing material loss of function during storage and product shipment, which occurs prior to therapies being delivered to patients. The company's MicroCNX ULT connectors provide an efficient and simple method for the sterile connection of tubing and are also compatible with harsh chemicals. Such launches are expected to aid in creating sterile connections outside the biosafety cabinets, allowing for easy transport of biological specimens.

Market leaders, including Merck KGaA, Thermo Fisher Scientific Inc., and Lonza Ltd. have established themselves in the field of cryopreservation technologies and innovative product offerings. These companies heavily invest in bio-preservation research, ensuring continuous innovation in cryopreservation media, freezing techniques, and automation, and focus on developing strategic partnerships and collaborations with biotech companies, research institutions, and biobanks to develop cutting-edge cryopreservation solutions. These companies also focus on investing in research and development activities to introduce novel protocols and technologies to tackle the different challenges faced by the cryopreservation industry.

Increasing Incidences of Infertility Drive Market Growth

The rise in the number of cases of infertility due to the increasing number of medical conditions that affect reproductive health and lifestyle changes are propelling the requirement for various fertility preservation technologies and procedures, propelling the market's demand. As more couples rely on fertility preservation technologies for parenthood, the requirement for cryopreservation equipment and consumables is rising to store sperm and embryos. Additionally, technological advancements in freezing and vitrification methods are allowing professionals to improve the viability and survival rates of preserved reproductive cells, ensuring successful outcomes.

The Institute for Health Metrics and Evaluation (IHME) estimates that, by 2050, over three quarters of countries will not have high enough fertility rates to sustain the size of the population over time. Thus, the reliance on fertility preservation technologies is expected to increase in the coming years, providing lucrative growth opportunities for the market.

Favorable Government Policies and Initiatives Support Market Expansion

Introduction of different policies and regulations that protect the privacy of the patients are further bolstering the market's expansion as the patient population feels more secure is availing different reproductive treatments. In the United States, the Health Insurance Portability and Accountability Act (HIPAA) plays a crucial role in protecting the privacy and security of reproductive health information, particularly in the context of fertility preservation. The new HIPAA regulations, effective June 25, 2024, establish stricter privacy protections for protected health information (PHI) related to reproductive health care. In Europe and the United Kingdom, the GDPR views genetic data as sensitive data or "special categories of personal data," making their processing for research applications subject to the adoption of technical and organizational safeguards, such as pseudonymization.

Additionally, policies also affect international collaborations in genetic research and cryopreservation as some countries impose restrictions on sharing genetic data across borders due to privacy concerns, impacting the cryopreservation industry. Political decisions influence whether cryopreservation services are covered under employer-sponsored health plans, some governments encourage companies to include such benefits in corporate health policies to boost the growth of the population.

Increasing Construction of Biobanks Boosts Market Demand

The rapid expansion of disease prevention research and increasing requirement for targeted therapies and precision medicine are propelling the requirement for biobanks. Various governments also provide funding and donations to biobanks to support and promote research activities across various domains. In February 2024, the UK government provided an additional USD 27 million (£21 million) for the USD 97 million (£75 million) UK Biobank Limited in Manchester.

Additionally, various integrated healthcare providers are also investing in the construction of biobank facilities in different regions across the globe. In May 2024, CIC Innovation Services LLC and CHA Medical & Bio Group signed a memorandum of understanding for establishing an open innovation center focusing on innovation and research around the Cell Gene Biobank (CGB). Both companies agreed to collaborate to create a biotech-focused innovation ecosystem for supporting and attracting biotech companies and related ventures to CGB, which is being constructed by the CHA Medical & Bio Group in Pangyo, South Korea. Such activities are expected to boost the growth of the research sector and positively influence the expansion of the global cell cryopreservation market.

Technological Advancements Support Market Expansion

The growing efforts by various biotech companies to bolster the development and availability of novel cell cryopreservation technologies to increase convenience and redefine standards for cryopreservation are boosting the global cell cryopreservation market growth. In October 2024, Nucleus Biologics, one of the leading providers of bioprocessing and cell culture solutions for the gene and cell therapy sector, launched NB-KUL DF, a chemically defined, DMSO-free cryomedia set to redefine the standards of cryopreservation. NB-KUL DF outperforms other DMSO-free options in cell expansion, viability, and recovery. Additionally, NB-KUL DF eliminates the issues associated with DMSO-based media, such as the requirement for complex wash steps, patient issues, and additional variability and costs. Such launches mark a new era for cell cryopreservation for therapies and showcase the biotech companies' efforts to create products that make therapies more accessible and consistent for patients.

Additionally, various biotech companies are entering into collaborations and partnerships with others to accelerate the development of novel products and technologies. In October 2023, Cryoport, Inc. and NMDP BioTherapies (formerly known as Be The Match BioTherapies) announced a partnership to expand the former's capabilities and provide global cryopreservation and bioprocessing support across Europe and the United States.

IVF Clinics Hold Significant Market Share

The rising cases of infertility and the increasing requirement for the freezing and donating of biological material are propelling the segment's expansion and bolstering the global cell cryopreservation market size. As per the estimates of the World Health Organization (WHO), 1 in 6 adults across the globe experience infertility in their lifetime. Thus, propelling the requirement for effective and dependable cryopreservation solutions to ensure the viability of frozen eggs and sperm for long periods of time. Additionally, the rising cases of infertility are also augmenting the construction of fertility clinics in various regions across the globe, providing lucrative growth opportunities to the market. In June 2024, a new state-of-the-art fertility clinic was opened in Walnut Creek, United States, to address the rising requirement for expert fertility care. The increasing acceptance and awareness of assisted reproductive technologies (ART) is also boosting the demand for cell cryopreservation tools by IVF clinics. Various government and non-government organizations (NGOs) are also working on raising awareness about infertility, destigmatizing ARTs, and promoting education and understanding.

North America Holds Major Market Share

The expansion of the North American cell cryopreservation market is driven by the increasing emphasis on research and development activities, rising investments in the biotech sector, and the presence of advanced healthcare infrastructure. Additionally, the strong presence of leading market players in the region also provides lucrative growth opportunities for the market by ensuring the availability of advanced and novel technologies. The increased product demand can also be attributed to the rising construction of biobanks in countries such as the United States to support medical research for developing new and personalized therapies.

Furthermore, the rising efforts of various companies and research organizations to expedite cell and gene therapy development and manufacturing are also propelling the market's demand. In June 2023, GenScript Biotech Corporation and Comprehensive Cell Solutions, a business unit of New York Blood Center, Inc., announced their partnership to spearhead the development of gene and cell therapies to offer seamless and unique solutions that span apheresis and cell collections through cryopreservation of final therapeutics. The partnership will also focus on aiding drug developers in advancing treatment options for immune disorders and blood cancer. Additionally, the increasing breakthroughs in the region in gene and cell therapies are further augmenting the demand for reliable cryopreservation equipment to support clinical trials, distribution, and manufacturing activities.

Future Market Scenario (2025-2032F)

As per the global cell cryopreservation market analysis, the increasing investments in biobanking, advancements in cryoprotectant formulations, and automated cryopreservation systems are expected to provide lucrative growth opportunities to the market. Private organizations and governments across the globe are significantly investing in establishing biobanks to support drug discovery and disease research. Such initiatives are anticipated to boost the market's growth as biobanking facilities rely on effective cryopreservation technologies for storing biological specimens and ensuring they remain viable for future use. The growing popularity of personalized medicines is also expected to bolster the demand for efficient cell storage solutions, propelling the global cell cryopreservation market demand.

Moreover, the growing focus on cell-based therapies for treating autoimmune diseases, neurological disorders, and cancer, among others, is also expected to bolster the requirement for cell cryopreservation products. According to the estimates of the World Health Organization (WHO), over 35 million new cases of cancer are expected to occur in 2050. Additionally, the market is also expected to benefit from the increasing initiatives that aim to improve the regulatory framework, allowing companies to bring novel products to the market with ease.

Impact of the U.S. Tariffs on Global Cell Cryopreservation Market

The tariffs are elevating the manufacturing expenses for cryopreservation equipment, including freezers, incubators, and liquid nitrogen supply tanks. These elevations are particularly challenging for small and medium sized clinical facilities, biobanks, and laboratories that are heavily reliant on such equipment. Additionally, the tariffs are also expected to cause significant disruptions in the supply chain as manufacturers may face significant challenges while sourcing different components, resulting in increased costs and delays. Furthermore, the need to relocate manufacturing locations and find alternative suppliers can further introduce operational complexities and increase expenses for medical device companies.

Key Players Landscape and Outlook

The rising efforts by the key market players towards novel product launches are providing lucrative growth opportunities for the market. In June 2023, BioLife Solutions Inc, one of the leading suppliers and developers of class-defining bioproduction services and products for gene and cell therapy, announced the launch of their new, large-capacity controlled-rate freezer (CRF). The IntelliRate i67C tabletop freezer fulfills the growing customer requirement for high production of cell therapies. The new CRF has been designed to increase single-batch, LN2 CRF capacity from commercial manufacturing volumes to late- and mid-stage clinical research. Additionally, in October 2024, Cryoport, Inc. announced the launch of their IntegriCell cryopreservation solution provided by Cryoport Systems, along with the opening of their new facility in Texas, United States. The new facility is developed for standardized cryopreservation of leukapheresis material to support the commercialization and development of cell-based therapies. IntegriCell is designed to enhance cell therapy manufacturing efficiency and ensure quality, safety, and product stability to support the development of lifesaving treatment. Such developments and investments are expected to aid the key players in expanding their market share while positively influencing the expansion of the cell cryopreservation market.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Cell Cryopreservation Market Outlook, 2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Consumables
      • 4.2.1.1.1. Cryogenic Vials
      • 4.2.1.1.2. Cryogenic Tubes
      • 4.2.1.1.3. Cooler Boxes/Containers
      • 4.2.1.1.4. Others
    • 4.2.1.2. Cell Freezing Media
      • 4.2.1.2.1. Ethylene Glycol
      • 4.2.1.2.2. Dimethyl Sulfoxide
      • 4.2.1.2.3. Glycerol
      • 4.2.1.2.4. Others
    • 4.2.1.3. Equipment
      • 4.2.1.3.1. Freezers
      • 4.2.1.3.2. Incubators
      • 4.2.1.3.3. Liquid Nitrogen Supply Tanks
  • 4.2.2. By Application
    • 4.2.2.1. Stem Cells
    • 4.2.2.2. Oocytes and Embryotic Cells
    • 4.2.2.3. Sperm Cells
    • 4.2.2.4. Hepatocytes
    • 4.2.2.5. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Biopharmaceutical and Pharmaceutical Companies
    • 4.2.3.2. Research Institutes
    • 4.2.3.3. Biobanks
    • 4.2.3.4. IVF Clinics
    • 4.2.3.5. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia-Pacific
    • 4.2.4.4. South America
    • 4.2.4.5. Middle East and Africa
  • 4.2.5. By Company Market Share Analysis

5. North America Cell Cryopreservation Market Outlook, 2018-2032F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. Consumables
      • 5.2.1.1.1. Cryogenic Vials
      • 5.2.1.1.2. Cryogenic Tubes
      • 5.2.1.1.3. Cooler Boxes/Containers
      • 5.2.1.1.4. Others
    • 5.2.1.2. Cell Freezing Media
      • 5.2.1.2.1. Ethylene Glycol
      • 5.2.1.2.2. Dimethyl Sulfoxide
      • 5.2.1.2.3. Glycerol
      • 5.2.1.2.4. Others
    • 5.2.1.3. Equipment
      • 5.2.1.3.1. Freezers
      • 5.2.1.3.2. Incubators
      • 5.2.1.3.3. Liquid Nitrogen Supply Tanks
  • 5.2.2. By Application
    • 5.2.2.1. Stem Cells
    • 5.2.2.2. Oocytes and Embryotic Cells
    • 5.2.2.3. Sperm Cells
    • 5.2.2.4. Hepatocytes
    • 5.2.2.5. Others
  • 5.2.3. By End-user
    • 5.2.3.1. Biopharmaceutical and Pharmaceutical Companies
    • 5.2.3.2. Research Institutes
    • 5.2.3.3. Biobanks
    • 5.2.3.4. IVF Clinics
    • 5.2.3.5. Others
  • 5.2.4. By Country Share
    • 5.2.4.1. United States
    • 5.2.4.2. Canada
    • 5.2.4.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Cell Cryopreservation Market Outlook, 2018-2032F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Product
        • 5.3.1.2.1.1. Consumables
        • 5.3.1.2.1.1.1. Cryogenic Vials
        • 5.3.1.2.1.1.2. Cryogenic Tubes
        • 5.3.1.2.1.1.3. Cooler Boxes/Containers
        • 5.3.1.2.1.1.4. Others
        • 5.3.1.2.1.2. Cell Freezing Media
        • 5.3.1.2.1.2.1. Ethylene Glycol
        • 5.3.1.2.1.2.2. Dimethyl Sulfoxide
        • 5.3.1.2.1.2.3. Glycerol
        • 5.3.1.2.1.2.4. Others
        • 5.3.1.2.1.3. Equipment
        • 5.3.1.2.1.3.1. Freezers
        • 5.3.1.2.1.3.2. Incubators
        • 5.3.1.2.1.3.3. Liquid Nitrogen Supply Tanks
      • 5.3.1.2.2. By Application
        • 5.3.1.2.2.1. Stem Cells
        • 5.3.1.2.2.2. Oocytes and Embryotic Cells
        • 5.3.1.2.2.3. Sperm Cells
        • 5.3.1.2.2.4. Hepatocytes
        • 5.3.1.2.2.5. Others
      • 5.3.1.2.3. By End-user
        • 5.3.1.2.3.1. Biopharmaceutical and Pharmaceutical Companies
        • 5.3.1.2.3.2. Research Institutes
        • 5.3.1.2.3.3. Biobanks
        • 5.3.1.2.3.4. IVF Clinics
        • 5.3.1.2.3.5. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Cell Cryopreservation Market Outlook, 2018-2032F

• 6.1. Germany
• 6.2. Spain
• 6.3. France
• 6.4. United Kingdom
• 6.5. Italy
• 6.6. Turkey
• 6.7. Russia
• 6.8. Netherlands
• 6.9. Poland

7. Asia-Pacific Cell Cryopreservation Market Outlook, 2018-2032F

• 7.1. China
• 7.2. Japan
• 7.3. India
• 7.4. South Korea
• 7.5. Australia
• 7.6. Vietnam
• 7.7. Indonesia
• 7.8. Philippines

8. Middle East and Africa Cell Cryopreservation Market Outlook, 2018-2032F

• 8.1. Saudi Arabia
• 8.2. UAE
• 8.3. South Africa

9. South America Cell Cryopreservation Market Outlook, 2018-2032F

• 9.1. Brazil
• 9.2. Argentina

10. Market Map Analysis, 2024

• 10.1. By Product
• 10.2. By Application
• 10.3. By End-user
• 10.4. By Region

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

• 17.1. Market Drivers
• 17.2. Market Challenges

18. Market Trends and Developments

19. Clinical Trials and Innovation

• 19.1. Clinical Trials
• 19.2. Innovations

20. Patent Landscape

21. Case Studies

22. Competitive Landscape

• 22.1. Competition Matrix of Top 5 Market Leaders
• 22.2. SWOT Analysis for Top 5 Players
• 22.3. Key Players Landscape for Top 10 Market Players
  • 22.3.1. Merck & Co., Inc.
    • 22.3.1.1. Company Details
    • 22.3.1.2. Key Management Personnel
    • 22.3.1.3. Products and Services
    • 22.3.1.4. Financials (As Reported)
    • 22.3.1.5. Key Market Focus and Geographical Presence
    • 22.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 22.3.2. Thermo Fisher Scientific Inc.
  • 22.3.3. Lonza Group Ltd.
  • 22.3.4. GE HealthCare Technologies Inc.
  • 22.3.5. BioLife Solutions Inc.
  • 22.3.6. Sartorius AG
  • 22.3.7. STEMCELL Technologies Canada Inc.
  • 22.3.8. Artivion, Inc
  • 22.3.9. Takara Bio Inc.
  • 22.3.10. Corning Incorporated

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

23. Strategic Recommendations

24. About Us and Disclaimer